ABBOTT PARK, Ill., July 11, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System. This new ...
Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...
ABBOTT PARK, Ill., June 14, 2017 — Abbott announced today that the Alinity hq analyzer for hematology is now CE Marked and available in Europe and other countries that recognize CE Mark. The analyzer ...
Abbott has received FDA approval for a new addition to its Alinity line of laboratory diagnostic hardware designed to screen blood and plasma donations for potential contaminants. The company ...
(RTTNews) - Abbott has received Emergency Use Authorization from the U.S. Food and Drug Administration for Covid-19 antibody blood test on Alinity i System. It is the company's fourth Covid-19 test to ...
KRAS-mutated tumors were once untreatable. In fact, KRAS was something of a poster child for so-called undruggability. Several laboratories are investigating ...
* ABBOTT - DATA SHOWS RELIABLE RESULTS WITH 99.6% SPECIFICITY AND 100% SENSITIVITY FOR PATIENTS TESTED 14 DAYS AFTER SYMPTOMS BEGAN * ABBOTT LABORATORIES - ABBOTT PLANS TO SHIP NEARLY 30 MILLION ...
The FDA urged clinical laboratories and healthcare providers to retest any patients who have recently received a positive result from two of Abbott’s PCR COVID-19 assays after identifying a heightened ...
A trio of new products has turned Abbott Laboratories into an unlikely growth story. The North Chicago medical device maker reported 7.6 percent organic revenue growth for the third quarter. It's the ...
(RTTNews) - Abbott has received Emergency Use Authorization from the U.S. Food and Drug Administration for Covid-19 antibody blood test on Alinity i System. It is the company's fourth Covid-19 test to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results